Artificial Joints Market Continues to Expand with Arthrex Introducing the U.S. FDA-Cleared SwiveLock ACL Repair Kit for Primary Repair of Anterior Cruciate Ligament (ACL) Tears

 


Replacement osteoarthritis, or artificial joint osteoarthritis, is a surgical procedure of arthroplasty orthopedics in which an arthritic, rotundar joint is substituted with an artificial orthopedic joint prosthesis. This procedure is used as a therapy for severely painful, dysfunctional, or arthritic joints. Artificial joint replacements allow patients to move without much pain and often restore the ability to function for long.

Increasing geriatric and obese population is expected to drive growth of the global artificial joints market. According to the World Health Organization (WHO), the global geriatric population is expected to account for around 22% of the global population by 2050. According to the same source, in Europe, the number of people aged 85 years and above is expected to increase from 14 million to 19 million by 2020, and increase to 40 million by 2050. Furthermore, according to the WHO, in 2016, around 1.9 billion adults aged 18 years and over were overweight, of which over 650 million were obese. Osteoarthritis is the most prevalent musculoskeletal disease affecting the geriatric and obese population, which in turn, has increased the demand for artificial joints. Hence, these factors are expected to drive growth of the global artificial joints market. Furthermore, technological advancements in artificial joints technology are expected to propel the global artificial joints market growth in the near future.  

High cost associated with artificial joints and frequent product recalls is expected to restrain growth of the global artificial joints market. However, rising R&D initiatives related to the development of novel artificial joints can present lucrative growth opportunities for key market players in the near future. Among regions, North America is expected to witness significant growth in the global artificial joints market. This is owing to the presence of robust healthcare infrastructure, continuous R&D activities for the development of artificial joints, and high healthcare expenditure across the region. Furthermore, Asia Pacific is expected to register a robust growth rate, owing to the presence of a large pool of population suffering from joint diseases.

Key companies involved in the global artificial joints market are JRI Orthopedics, Abbott Laboratories, Globus Medical, Boston Scientific, Aesculap AG, Stryker Corporation, Arthrex, Intuitive Surgical Inc., Sonova Holdings AG, Zimmer Biomet Holdings Inc., Varian Medical Systems, and Smith and Nephew plc.

For instance, in December 2020, Arthrex, a developer of minimally invasive orthopedic technology, launched the SwiveLock ACL Repair Kit, which is approved by the U.S. Food and Drug Administration (FDA), for primary repair of anterior cruciate ligament (ACL) tears.


Comments

Post a Comment

Popular posts from this blog

Increasing Consumption and Production of Fertilizers to Upsurge the Growth of the Agrochemicals Market

Image
  Agrochemical products are those chemicals that are used to increase the production of an agricultural environment. Agrochemical chemicals typically include pesticides, fertilizers, lime precursors, acidizing and alkalizing agents (all of which are designed to alter the normal pH level of the soil), lime stabilizers, and other nutrients that are required for plant growth. These chemicals are widely used by farmers and are crucial to the functioning of modern agriculture. The use of these chemicals presents a number of concerns both from the perspective of the environment and the human body. The increasing need for improving crop production due to the growing concern of food security and lack of arable land is fueling the growth of agrochemicals market . Growing advancement in technology is raising adoption of advanced and sustainable farming practices which is again propelling the growth of the market. The increasing population coupled with the growing usage of fertilizers aroun...
Read more

High Prevalence of Cancer and R&D in Anti-Cd39 Antibodies to Augment Growth of Anti-body Coupled T Receptor Therapy Market

Image
  Antibody-Coupled T cell Receptor (ACTR) is an autologous engineered T cell therapy that combines the Fc receptor, CD16, with endogenous T cell signaling and costimulatory domains. It is combined with tumor-targeting antibodies to exert potent anti-tumor immune responses and eliminate cancerous cells. ACRT has demonstrated potential in the treatment of multiple myeloma and HER2+ advanced cancers. Market Dynamics R&D in anti-CD39 antibodies is expected to propel growth of the Anti-body Coupled T Receptor Therapy Market . For instance, in December 2020, Arcus Biosciences, Inc. expanded its existing partnership with WuXi Biologics, a developer of biologics technology platforms, for R&D in anti-CD39 antibodies using WuXi Bio’s proprietary technology. Moreover, high prevalence of cancer is also expected to aid in growth of the market. For instance, according to the American Cancer Society, in 2019, there will be an estimated 1,762,450 new cancer cases diagnosed and 606,880 ...
Read more

Increasing Prevalence of Muscular Dystrophy to Augment the Muscular Dystrophy Treatment Market Growth

Image
  Muscular dystrophy is a common disease that causes muscles to become weaker and unable to continue to develop properly. Because it often affects young children as well as adults, it can be difficult to detect. However, once symptoms are noticed, steps must be taken to prevent the disease. There are many treatment options available for muscular dystrophy. The severity of the disease will determine what type of treatment is best for your situation. Muscular dystrophy treatment involves breathing aids, therapy, surgery, or medication, which may help maintain function, but life span is often shortened. Market Dynamics: Increasing prevalence or incidence of muscular dystrophy, especially in the North America, is expected to propel the growth of the muscular dystrophy treatment market . For instance, one in 3,500 male babies born worldwide are affected with Duchenne muscular dystrophy (DMD), according to the National Organization for Rare Disorders. Moreover, in 2019, around 349 ne...
Read more